As the Chief Business Officer at Sernova Corp., a leading biotechnology company developing novel cell therapies for chronic diseases, I leverage my 25+ years of diverse industry experience to drive innovation, growth, and value creation. I oversee the global business strategy, portfolio management, operations, strategic marketing, and partnerships, as well as capital raise, M&A, and licensing activities.
I have a proven track record of building and leading world-class cross-functional teams, developing and launching innovative products, delivering multimillion-dollar bottom-line results, and establishing fruitful collaborations with various stakeholders.
My core competencies include strategic thinking, active listening, collaborative negotiation, cross-functional leadership, and high performance, which enable me to facilitate and empower the development and commercialization of multi-product and multi-indication biotech and pharma products.
I am currently an Investment Advisor to 2Flo Ventures, a Strategic Advisor to Peqish Food Co and a Member of Board of Directors of Temprian Therapeutics.
My mission is to transform the lives of patients and improve the healthcare system through equitable and accessible innovation.